Literature DB >> 29020338

Is Moderate Alcohol Consumption Safe for Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Women?

Vincent Lo Re1,2.   

Abstract

Entities:  

Keywords:  HIV; alcohol; hepatitis C; liver fibrosis

Mesh：

Year:  2017        PMID： 29020338      PMCID： PMC5848333          DOI： 10.1093/cid/cix720

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  12 in total

1.  Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection.

Authors:  Richard K Sterling; Eduardo Lissen; Nathan Clumeck; Ricard Sola; Mendes Cassia Correa; Julio Montaner; Mark S Sulkowski; Francesca J Torriani; Doug T Dieterich; David L Thomas; Diethelm Messinger; Mark Nelson
Journal:  Hepatology       Date:  2006-06       Impact factor: 17.425

2.  Relationship between alcohol use categories and noninvasive markers of advanced hepatic fibrosis in HIV-infected, chronic hepatitis C virus-infected, and uninfected patients.

Authors:  Joseph K Lim; Janet P Tate; Shawn L Fultz; Joseph L Goulet; Joseph Conigliaro; Kendall J Bryant; Adam J Gordon; Cynthia Gibert; David Rimland; Matthew Bidwell Goetz; Marina B Klein; David A Fiellin; Amy C Justice; Vincent Lo Re
Journal:  Clin Infect Dis       Date:  2014-02-25       Impact factor: 9.079

Review 3.  Alcohol use and hepatitis C.

Authors:  Marion G Peters; Norah A Terrault
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

4.  Risk of mortality and physiologic injury evident with lower alcohol exposure among HIV infected compared with uninfected men.

Authors:  Amy C Justice; Kathleen A McGinnis; Janet P Tate; R Scott Braithwaite; Kendall J Bryant; Robert L Cook; E Jennifer Edelman; Lynn E Fiellin; Matthew S Freiberg; Adam J Gordon; Kevin L Kraemer; Brandon D L Marshall; Emily C Williams; David A Fiellin
Journal:  Drug Alcohol Depend       Date:  2016-01-29       Impact factor: 4.492

5.  High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US cities.

Authors:  Jennifer V Campbell; Holly Hagan; Mary H Latka; Richard S Garfein; Elizabeth T Golub; Micaela H Coady; David L Thomas; Steffanie A Strathdee
Journal:  Drug Alcohol Depend       Date:  2005-08-29       Impact factor: 4.492

6.  Hazardous drinking is associated with an elevated aspartate aminotransferase to platelet ratio index in an urban HIV-infected clinical cohort.

Authors:  A A Chaudhry; M S Sulkowski; G Chander; R D Moore
Journal:  HIV Med       Date:  2008-12-20       Impact factor: 3.180

7.  Who needs direct-acting antivirals for HCV? Challenges faced in advancing HCV therapy for HIV-HCV-coinfected individuals.

Authors:  Marina B Klein; Kathleen C Rollet; Mark Hull; Curtis Cooper; Sharon Walmsley; Brian Conway; Neora Pick
Journal:  Antivir Ther       Date:  2012-12-04

8.  Alcohol consumption and HIV disease progression.

Authors:  Jeffrey H Samet; Debbie M Cheng; Howard Libman; David P Nunes; Julie K Alperen; Richard Saitz
Journal:  J Acquir Immune Defic Syndr       Date:  2007-10-01       Impact factor: 3.731

9.  Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study.

Authors:  Vincent Lo Re; Michael J Kallan; Janet P Tate; A Russell Localio; Joseph K Lim; Matthew Bidwell Goetz; Marina B Klein; David Rimland; Maria C Rodriguez-Barradas; Adeel A Butt; Cynthia L Gibert; Sheldon T Brown; Lesley Park; Robert Dubrow; K Rajender Reddy; Jay R Kostman; Brian L Strom; Amy C Justice
Journal:  Ann Intern Med       Date:  2014-03-18       Impact factor: 25.391

10.  Moderate Alcohol Use Is Not Associated With Fibrosis Progression in Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Women: A Prospective Cohort Study.

Authors:  Erin M Kelly; Jennifer L Dodge; Peter Bacchetti; Monika Sarkar; Audrey L French; Phyllis C Tien; Marshall J Glesby; Elizabeth T Golub; Michael Augenbraun; Michael Plankey; Marion G Peters
Journal:  Clin Infect Dis       Date:  2017-11-29       Impact factor: 9.079
View more
  2 in total

1.  Insights Into the Pathophysiology of Liver Disease in HCV/HIV: Does it End With HCV Cure?

Authors:  Andre J Jeyarajan; Raymond T Chung
Journal:  J Infect Dis       Date:  2020-11-27       Impact factor: 5.226

2.  HIV and the liver.

Authors:  Kenneth E Sherman; Marion G Peters; David L Thomas
Journal:  Top Antivir Med       Date:  2019-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.